We are live on ! Find out more
GAM

Goldentree Asset Management Portfolio holdings

AUM $1.69B
1-Year Est. Return 10.69%
This Fund
S&P 500
This Quarter Est. Return
+16.21%
1 Year Est. Return
+10.69%
3 Year Est. Return
+41.11%
5 Year Est. Return
+102.8%
10 Year Est. Return
+125.11%
AUM
$926M
AUM Growth
+$292M
Cap. Flow
+$217M
Cap. Flow %
23.46%
Top 10 Hldgs %
79.05%
Holding
32
New
6
Increased
10
Reduced
7
Closed
7

Sector Composition

Rank Sector Weight
1 Communication Services 29.6%
2 Healthcare 14.53%
3 Financials 7.22%
4 Industrials 7.2%
5 Utilities 6.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRSL
26
Brightstar Lottery PLC
BRSL
$2.02B
-1,934,106
Closed -$28.3M
MTG icon
27
MGIC Investment
MTG
$6.25B
-998,037
Closed -$10.4M
NVR icon
28
NVR
NVR
$17.1B
-2,125
Closed -$5.18M
XRX icon
29
Xerox
XRX
$428M
-362,200
Closed -$7.16M
UNVR
30
DELISTED
Univar Solutions Inc.
UNVR
-266,845
Closed -$4.73M
NXEO
31
DELISTED
Nexeo Solutions, Inc. Common Stock
NXEO
-318,000
Closed -$2.73M
CZR
32
DELISTED
Caesars Entertainment Corporation
CZR
-7,584,413
Closed -$51.5M

Similar funds

Goldentree Asset Management's Q1 2019 Portfolio in Review

As of Q1 2019, Goldentree Asset Management held 32 positions worth $926M, up 46% from $634M the previous quarter. Its ten largest holdings account for 79% of the portfolio.

Goldentree Asset Management deployed $217M of net new capital in Q1 2019, opening 6 new positions and adding to 10 existing holdings. Its largest new stake was G-III Apparel Group: 409,650 shares worth $16.4M.

By sector, the portfolio is most concentrated in Communication Services at 30% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $14.8M trimmed.

  • Goldentree Asset Management's largest Q1 2019 buy was G-III Apparel Group: 409,650 shares worth $16.4M.
  • Goldentree Asset Management added most to OI S.A. American Depositary Shares, each representing five shares of common stock in Q1 2019, an estimated $131M increase.
  • Goldentree Asset Management's biggest Q1 2019 reduction was Teva Pharmaceuticals, cutting an estimated $14.8M.
  • Goldentree Asset Management fully exited Caesars Entertainment Corporation in Q1 2019, selling an estimated $51.5M.
  • Goldentree Asset Management's ten largest holdings make up 79% of its $926M portfolio in Q1 2019.
  • Goldentree Asset Management opened 6 new positions and closed 7 in Q1 2019.
  • Goldentree Asset Management's portfolio value rose 46% quarter-over-quarter to $926M.

Based on Goldentree Asset Management's 13F filing for Q1 2019, filed 15 May 2019.